DNA Repair Drugs Market Research Overview Of Industry Share Perspectives Shared In A Comprehensive Report


DNA repair is a collection of processes by which a cell recognizes and corrects damage to the DNA molecules that encode its genome. DNA repair drugs are used in repairing damaged DNA and for treating cancers. DNA damage results in genetic disorders; however, the human body has its mechanisms to correct the DNA sequence. DNA repair drugs such as PARP inhibitors and other DNA repair drugs help to treat diseases with genetic aberrations.

Increasing incidences of cancer, increasing collaboration and acquisition with product launch by market players are major factors driving global DNA repair drugs market growth. In May 2019, AstraZeneca and Merck received the Health Canada approval for Lynparza as monotherapy maintenance treatment for patients with advanced high-grade epithelial ovarian cancer, fallopian tube or primary peritoneal cancer.

Furthermore, inorganic strategies adopted by key players to enhance their product portfolio is expected to drive the market growth. In May 2019, Clovis Oncology, Inc., in collaboration with Bristol-Myers Squibb Company and Foundation Medicine Inc., initiated Phase II trials to evaluate rucaparib in combination with nivolumab in patients with high-grade serous carcinoma (HGSC) or endometrioid ovarian cancer.

The global DNA repair drugs market is highly concentrated due to the presence of key players. A large number of manufacturers hold major share in their respective regions. Demand for technologically advaced products has increased in emerging as well as developed markets, owing to rise in prevalence of cancer. Growth strategies adopted by leading players are likely to drive the global market.

Major players operating in the global DNA repair drugs market are AstraZeneca Plc., Johnson & Johnson, GlaxoSmithKline plc., Pfizer, Inc., Clovis Oncology Inc., AbbVie Inc., Bristol - Myers Squibb, Merck KGaA, Genentech, Inc., Repare Therapeutics Inc., Karyopharm Therapeutics Inc., Ono Pharmaceutical Co., LTD., and Jiangsu Hengrui Medicine Co., Ltd.

Comments

Post a Comment

Popular posts from this blog

U.S. Meibomian Gland Dysfunction Market is growing rapidly with ThermaMEDx introducing a self-healing, disposable, pre-moistened, sterile cleaning eye-pad for use in treating the symptoms of dry eyes and meibomian gland dysfunction

Image
Dysfunction of any of these three glands can result in Meibomian gland dysfunction. A primary cause for this condition is not really the disease itself but rather the abnormal overproduction of sebum (the secreted liquid of glands). This is normally controlled by the hypothalamus-pituitary gland system which inhibits the secretion of oil. Rapidly increases the prevalence of meibomian gland dysfunction remains one of the critical factors aiding the development of the market. In fact, as per the Fellow of American College of Surgeons, meibomian gland disease, is one of the most common causes of dry eyes and around 50-70% of the elderly population has some degree of dry eye. Besides, as per the American Optometric Association’s study in 2017, over 16 million people in the U.S. were suffering from dry eye disease. Such factors can indeed stimulate growth of the U.S. meibomian gland dysfunction market. When it comes to the drug type, Cyclosporine segment seems to be exhibiting positive trac...
Read more

Boston Sci Launched A New Device For Erectile Dysfunction Devices Market

Image
  North America is expected to hold the major share in the global erectile dysfunction devices market and this is attributed to the continuous innovation in the device by key players in the region. For instance, in July 2019, Boston Scientific announced the launch of the Tactra penile implant, which is a durable implant with a natural feel for treating ED. Also, in August 2019, Ohio, U.S.-based Integrated Medical announced that they are offering a state-of-the-art Extra Corporeal Shock Wave Therapy (ESWT) for treating ED. The therapy will utilize power generated through acoustic sound waves and radial shockwaves to stimulate neovascularization The growing prevalence of cardiovascular or diabetes disease among men undergoing such treatment are at higher risk of developing erectile dysfunction. This is driving the growth of the  erectile dysfunction devices market . Vacuum pumps, also known as Vacuum Erection devices (VED) are gaining huge demand around the globe. According to t...
Read more

Bakeable Trays Market Estimated To Develop At Cagr at 4.8% During Estimate Duration 2019-2027

Image
The expansion of direct bundle to-broiler pastry shop items have pushed the market for bakeable trays. While these items have been around for some time, the rise of new sorts of bakeable trays features the market's development as of late. Contrasted with the conventional preparing trays which are comprised of metal, the bakeable trays are produced using a ridged paper card board that is both warmth safe and water confirmation. Such trays are made to withstand temperatures up to 220°C. These bakeable or ovenable trays are offered in various sizes and shapes. Bakeable trays can even be tweaked for various end use applications. One of the differentiating highlights of bakeable trays is that they are made of bio-degradable substance and are recyclable. These are likewise endorsed by different food organizations for direct food contact making it more secure to buyer straightforwardly from them. The worldwide  bakeable trays market  is required to arrive at US$ 1,943.8 million by 20...
Read more